From Wikipedia, the free encyclopedia
|Systematic (IUPAC) name|
|(what is this?)|
BD-1047 is a sigma receptor antagonist, selective for the σ1 subtype. It has effects in animal studies suggestive of antipsychotic activity and may also be useful in the treatment of neuropathic pain.
- Skuza G, Rogóz Z (2006). "Effect of BD 1047, a sigma1 receptor antagonist, in the animal models predictive of antipsychotic activity". Pharmacological Reports : PR 58 (5): 626–35. PMID 17085854.
- Roh DH, Kim HW, Yoon SY, Seo HS, Kwon YB, Kim KW, Han HJ, Beitz AJ, Na HS, Lee JH (November 2008). "Intrathecal injection of the sigma(1) receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain". Anesthesiology 109 (5): 879–89. doi:10.1097/ALN.0b013e3181895a83. PMID 18946301.
|This pharmacology-related article is a stub. You can help Wikipedia by expanding it.|